arrow
返回
J

Janssen Biotech Inc

学者数860
论文数638
被引数0
关联论文 (635)
发表时间
Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 InhibitionMoedt, E.; Koshino, A.; Jongs, N.; Ju, W.; Hansen, M.K.; Arnott, C.G.; Neal, B.; Bakker, S.J.; Heerspink, H.J.L. 尿表皮生长因子与肾脏结局的关系以及钠-葡萄糖协同转运蛋白2抑制的影响. J. Am. Soc. Nephrol. 2026. [Google Scholar] [CrossRef] [PubMed]
err2026-04-01
err1
PREAI
errMoedt, Erik; Koshino, Akihiko; Jongs, Niels; Ju, Wenjun; Nair, Viji; Kretzler, Matthias; Hansen, Michael K.; Arnott, Clare G.; Wheeler, David C.; Rossing, Peter; Coca, Steven G.; Hammarstedt, Ann; Greasley, Peter J.; Bjornstad, Petter; Bakker, Stephan J. L.; Heerspink, Hiddo J. L.
err分享
err收藏
G2-PASE: A Novel, Rapid, and Reliable Measure of Plaque Psoriasis SeverityG2-PASE:一种新颖、快速且可靠的银屑病斑块严重程度测量方法
err2026-02-01
err0
errOAAI
errGulliver, Wayne P.; Langholff, Wayne; Guenther, Lyn; Prajapati, Vimal H.; Ringuet, Julien; Yadav, Om Prakash; Gulliver, Susanne R.; Fakharzadeh, Steve; Lafferty, Kim Parnell; Abbarin, Nastaran; Gniadecki, Robert
err分享
err收藏
Blood-based biomarkers of gut barrier integrity associate with disease activity and future disease progression in inflammatory bowel disease肠道屏障完整性相关的血液生物标志物与炎症性肠病的疾病活动度和未来疾病进展相关
err2026-01-01
err0
PREAI
errGeertsema, S.; Bourgonje, A. R.; Veenstra, F.; Gacesa, R.; Fagundes, R. R.; Spekhorst, L.; Hu, S.; de Jong, S.; Jansen, B. H.; Holstein, H.; Ruane, D.; Kannan, A. K.; Weersma, R. K.; van Goor, H.; Dijkstra, G.; Faber, K. N.
err分享
err收藏
Macitentan Plus Tadalafil Single-Tablet Combination Therapy in Chinese Patients With Pulmonary Arterial Hypertension: A Subgroup Analysis of the A DUE StudyMacitentan Plus Tadalafil单片复方制剂治疗中国肺动脉高压患者的疗效:A DUE研究亚组分析
err2025-11-16
err0
errOAAI
errFan, Fenling; Sun, Luying; Yang, Zhenwen; Wang, Lan; Wang, Qiguang; Li, Jiang; Gu, Hong; Xie, Weiping; Zhang, Nuofu; Bin, Jia; Rofael, Hany; Friberg, Michael; Hauser, Jakob A.
err分享
err收藏
Biosynthesis and structure assignment of a hydroxylated metabolite of the orexin-1 receptor antagonist JNJ-61393215
err2025-04-01
err0
PREAI
errSong, Fengbin; Chen, Jie; Dallas, Shannon; Lam, Wing; Lim, Heng-Keang; Zhou, Ronghui; Kokubun, Tetsuo; Phipps, Richard; Steele, Jonathan; Salter, Rhys
err分享
err收藏
err分享
err收藏
Systematic review of applied transportability and generalizability analyses: A landscape analysis
err2025-03-01
err0
errOAAI
errVuong, Quang; Metcalfe, Rebecca K.; Ling, Albee; Ackerman, Benjamin; Inoue, Kosuke; Park, Jay J. H.
err分享
err收藏
Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials
err2025-02-21
err0
errOAAI
errHoran, William P.; Kalali, Amir; Brannan, Stephen K.; Drevets, Wayne; Leoni, Matthew; Mahableshwarkar, Atul; Martin, William J.; Rao, Srinivas; Reuteman-Fowler, Corey; Sauder, Colin; Savitz, Adam; Singh, Jaskaran; Tiller, Jane; Walker, Gary; Wendland, Jens R.; Harvey, Philip D.
err分享
err收藏
RADAR-AD: assessment of multiple remote monitoring technologies for early detection of Alzheimer's disease
err2025-01-27
err0
errOAAI
errLentzen, Manuel; Vairavan, Srinivasan; Muurling, Marijn; Alepopoulos, Vasilis; Atreya, Alankar; Boada, Merce; de Boer, Casper; Conde, Pauline; Curcic, Jelena; Frisoni, Giovanni; Galluzzi, Samantha; Gjestsen, Martha Therese; Gkioka, Mara; Grammatikopoulou, Margarita; Hausner, Lucrezia; Hinds, Chris; Lazarou, Ioulietta; de Mendonca, Alexandre; Nikolopoulos, Spiros; Religa, Dorota; Scebba, Gaetano; Visser, Pieter Jelle; Wittenberg, Gayle; Narayan, Vaibhav A.; Coello, Neva; Brem, Anna-Katharine; Aarsland, Dag; Froehlich, Holger; RADAR AD
err分享
err收藏
Response to Commentaries对评论的答复
err2025-01-25
err0
errOAAI
errHoran, William P.; Kalali, Amir; Brannan, Stephen K.; Drevets, Wayne; Mahableshwarkar, Atul; Rao, Srinivas; Reuteman-Fowler, Corey; Savitz, Adam; Singh, Jaskaran; Walker, Gary; Wendland, Jens R.; Harvey, Philip D.
err分享
err收藏
Guselkumab maintenance treatment improves health-related quality of life in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR maintenance study
err2025-01-22
err0
PREAI
errBressler, B.; Peyrin-Biroulet, L.; Afif, W.; Samaan, M. A.; Wei, S. C.; Yarandi, S.; Germinaro, M.; Mistry, P.; Han, C.; Allegretti, J. R.; Lichtenstein, G. R.
err分享
err收藏
Efficacy and safety of subcutaneous guselkumab induction therapy in patients with moderately to severely active Crohn's disease: Results through Week 48 from the phase 3 GRAVITI study
err2025-01-22
err0
PREAI
errHart, A.; Panaccione, R.; Steinwurz, F.; Danese, S.; Hisamatsu, T.; Cao, Q.; Olurinde, M.; Vetter, M. L.; Yang, Z.; Wang, Y.; Johanns, J.; Terry, N. A.; Sands, B. E.; D'Haens, G.
err分享
err收藏
Early disease efficacy of guselkumab therapy in biologic-naive patients with moderately to severely active Crohn's disease: Post-hoc analysis from the phase 3 GALAXI 2 & 3 studies
err2025-01-22
err0
PREAI
errAfzali, A.; Rubin, D. T.; Danese, S.; Rayyan, Y.; Chen, M.; Terry, N. A.; Salese, L.; Van Rampelbergh, R.; Yee, J.; Gomez, M.; Wan, K. Y. Y.; Yang, Z.; Sands, B. E.; D'Haens, G.
err分享
err收藏
Guselkumab improves health-related quality of life as measured by PROMIS-29 in participants with moderately to severely active Crohn's disease: Phase 3 GRAVITI study
err2025-01-22
err0
PREAI
errSands, B.; Danese, S.; Cao, Q.; Steinwurz, F.; Kierkus, J.; Han, C.; Olurinde, M.; Yang, Z.; Merrall, E.; Terry, N. A.; Hart, A.
err分享
err收藏
Efficacy by baseline disease characteristics of subcutaneous guselkumab induction therapy in patients with moderately to severely active Crohn's disease: Results at Week 12 from the phase 3 GRAVITI study
err2025-01-22
err0
PREAI
errD'Haens, G.; Hisamatsu, T.; Steinwurz, F.; Hart, A.; Liu, W.; Olurinde, M.; Ngqawa, P.; Yang, Z.; Merrall, E.; Terry, N. A.; Sands, B. E.; Panaccione, R.
err分享
err收藏
Comparison of pharmacodynamic and mechanistic response of guselkumab intravenous and subcutaneous induction in moderately to severely active Crohn's disease: molecular analysis of the GRAVITI and GALAXI Phase 3 studies
err2025-01-22
err0
PREAI
errRichards, D.; Patel, R.; Sohn, K.; Hart, A.; Lee, T.; Liu, J.; Sisk, C.; Olurinde, M.; Terry, N.; Mcrae, B.; Reinisch, W.; Feagan, B.; Steinwurz, F.; Panaccione, R.; D'Haens, G.; Branigan, P.
err分享
err收藏
Corticosteroid sparing effects of treatment with guselkumab in patients with moderately to severely active Crohn's disease: Phase 3 GRAVITI study results through week 48
err2025-01-22
err0
PREAI
errHart, A.; Panaccione, R.; Steinwurz, F.; Cao, Q.; Hisamatsu, T.; Nancey, S.; Olurinde, M.; Yang, Z.; Merrall, E.; Terry, N. A.; Sands, B. E.
err分享
err收藏
Guselkumab efficacy and safety in East Asian participants with moderate to severely active Ulcerative Colitis: Subgroup analysis of the Phase 2b/3 QUASAR induction and maintenance studies
err2025-01-22
err0
PREAI
errChen, B.; Ye, B. D.; Cao, Q.; Hirai, F.; Saruta, M.; Chen, M.; Pelak, S.; Shipitofsky, N.; Wahking, B.; Zhuo, J.; Hisamatsu, T.
err分享
err收藏